Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, the first modular mRNA workshop in China, has been delivered
Media
Sep 7, 2021
Walvax
On September 1, 2021, Walvax’s modular workshop for SARS-CoV-2 mRNA Vaccine, was officially delivered. It is an advanced process combining modular buildings with conventionally built facilities, which allows for tighter construction and can accelerate the industrialization schedule of SARS-CoV-2 mRNA Vaccine. Construction of modular buildings can occur simultaneously with the site and foundation work, allowing projects to be completed in a shorter period.
Related Links
Jul 5, 2023
Walvax publishes safety and non-inferior immunogenicity results of its MPV ACYW135 compared with Menactra® in Human Vaccines & Immunotherapeutics
Learn More
Mar 20, 2025
Walvax Showcases PPSV23 Vaccine Safety Data at VIF World 2025 in Shanghai
Learn More
Nov 27, 2025
Launch Event for Walvax’s PCV13 (Weuphoria) Successfully Held in Cairo, Egypt, Advancing National Vaccine Localization Vision
Learn More